4//SEC Filing
Protea Biosciences Group, Inc. 4
Accession 0001144204-14-065320
CIK 0001335103operating
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:47 PM ET
Size
10.6 KB
Accession
0001144204-14-065320
Insider Transaction Report
Form 4
HARRIS LEONARD P
Director
Transactions
- Conversion
Warrant
2014-10-31+339,388→ 1,793,069 totalExercise: $0.38From: 2014-10-31Exp: 2017-10-31→ Common Stock (339,388 underlying) - Conversion
Series A Convertible Preferred Stock
2014-10-31+84,847→ 84,847 total→ Common Stock (678,776 underlying) - Conversion
Convertible Note
2014-10-31From: 2014-10-31Exp: 2014-10-31→ Series A Convertible Preferred Stock & Warrants
Footnotes (2)
- [F1]The Issuer issued Series A Convertible Preferred Stock (the "Preferred Stock") in connection with the conversion of $169,696 outstanding principal and accrued unpaid interest of certain covertible promissory notes (the "Notes") to Leonard Harris (the "Reporting Person"). Each share of Preferred Stock has a stated value equal to $2.00, subject to increase based on the accrual of a 6% dividend (the "Stated Value"). The Preferred Stock will automatically convert into shares of Common Stock determined by dividing the Stated Value by $0.25 per share on February 17, 2015, subject to extension.
- [F2]In connection with the conversion of the Notes, the Reporting Person also received a 3 year warrant to purchase 339,388 shares of the Company's common stock, exercisable at $0.375 per share.
Documents
Issuer
Protea Biosciences Group, Inc.
CIK 0001335103
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001335103
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 4:47 PM ET
- Size
- 10.6 KB